Management of Diabetes Insipidus following Surgery for Pituitary and Suprasellar Tumours.

Arginine Vasopressin Central Diabetes Insipidus Desmopressin Pituitary Adenoma Pituitary Surgery Polydipsia Polyuria Preoperative Risk Factor Treatment

Journal

Sultan Qaboos University medical journal
ISSN: 2075-0528
Titre abrégé: Sultan Qaboos Univ Med J
Pays: Oman
ID NLM: 101519915

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 02 06 2020
revised: 14 08 2020
accepted: 09 08 2020
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 18 9 2021
Statut: ppublish

Résumé

Central diabetes insipidus (CDI) is a common complication after pituitary surgery. However, it is most frequently transient. It is defined by the excretion of an abnormally large volume of dilute urine with increasing serum osmolality. The reported incidence of CDI after pituitary surgery ranges from 0-90%. Large tumour size, gross total resection and intraoperative cerebrospinal fluid leak usually pose an increased risk of CDI as observed with craniopharyngioma and Rathke's cleft cysts. CDI can be associated with high morbidity and mortality if not promptly recognised and treated on time. It is also essential to rule out other causes of postoperative polyuria to avoid unnecessary pharmacotherapy and iatrogenic hyponatremia. Once the diagnosis of CDI is established, close monitoring is required to evaluate the response to treatment and to determine whether the CDI is transient or permanent. This review outlines the evaluation and management of patients with CDI following pituitary and suprasellar tumour surgery to help recognise the diagnosis, consider the differential diagnosis, initiate therapeutic interventions and guide monitoring and long-term management.

Identifiants

pubmed: 34522399
doi: 10.18295/squmj.4.2021.010
pii: squmj2108-354-364
pmc: PMC8407907
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

354-364

Informations de copyright

© Copyright 2021, Sultan Qaboos University Medical Journal, All Rights Reserved.

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST The authors declare no conflicts of interest.

Références

Endocr Connect. 2018 Jul;7(7):G8-G11
pubmed: 29930026
Baillieres Clin Obstet Gynaecol. 1987 Dec;1(4):853-71
pubmed: 3330489
Oper Neurosurg (Hagerstown). 2019 Jun 1;16(6):675-684
pubmed: 30247673
J Pediatr. 2002 Nov;141(5):618-24
pubmed: 12410188
J Pediatr. 1978 Jun;92(6):1011-5
pubmed: 660339
NDT Plus. 2010 Feb;3(1):42-44
pubmed: 20090880
Neurosurgery. 2008 Jan;62(1):71-8; discussion 78-9
pubmed: 18300893
J Neurosurg. 2009 Sep;111(3):555-62
pubmed: 19199508
Clin Endocrinol (Oxf). 2004 May;60(5):584-91
pubmed: 15104561
Clin Endocrinol (Oxf). 2019 Jan;90(1):23-30
pubmed: 30269342
Pituitary. 2008;11(4):391-401
pubmed: 18320327
Clin Biochem. 2003 Mar;36(2):109-12
pubmed: 12633759
Emerg Med Pract. 2012 Oct;14(10):1-26
pubmed: 23114652
Intensive Care Med. 1979 Mar;5(1):27-31
pubmed: 35558
J Clin Invest. 1964 Aug;43:1625-40
pubmed: 14201546
J Clin Endocrinol Metab. 2002 Oct;87(10):4564-8
pubmed: 12364435
Childs Nerv Syst. 2013 Jun;29(6):941-9
pubmed: 23386174
Clin Endocrinol (Oxf). 1997 Oct;47(4):405-9
pubmed: 9404436
Clin Endocrinol (Oxf). 2004 Aug;61(2):273-9
pubmed: 15272926
Am J Med. 1995 Oct;99(4):348-55
pubmed: 7573088
World Neurosurg. 2017 May;101:1-10
pubmed: 28153615
Neurosurgery. 2002 Apr;50(4):749-55; discussion 755-6
pubmed: 11904025
J Pediatr Endocrinol Metab. 2007 Apr;20(4):459-69
pubmed: 17550208
Intensive Care Med. 1986;12(2):95-9
pubmed: 3700841
Cancer. 2004 Aug 1;101(3):613-9
pubmed: 15274075
J Clin Endocrinol Metab. 2012 Oct;97(10):3426-37
pubmed: 22855338
J Clin Endocrinol Metab. 2013 Aug;98(8):3229-37
pubmed: 23690314
N Engl J Med. 1981 Dec 24;305(26):1539-46
pubmed: 7311993
Am J Physiol. 1987 Jun;252(6 Pt 2):R1138-42
pubmed: 3591984
Ther Adv Endocrinol Metab. 2017 Mar;8(3):33-48
pubmed: 28377801
Acta Med Acad Sci Hung. 1975;32(1):75-84
pubmed: 1233863
J Clin Endocrinol Metab. 2015 Jun;100(6):2268-74
pubmed: 25768671
Acta Med Scand. 1972 Jul-Aug;192(1-2):21-7
pubmed: 5052390
Am J Dis Child. 1989 Feb;143(2):201-4
pubmed: 2916492
BMJ. 1989 Jan 7;298(6665):2-3
pubmed: 2492841
N Engl J Med. 1976 Mar 4;294(10):507-11
pubmed: 1250255
J Clin Endocrinol Metab. 2007 Oct;92(10):3973-8
pubmed: 17635944
Crit Care Med. 1987 Jan;15(1):44-6
pubmed: 2431834
Pituitary. 2017 Jun;20(3):372-380
pubmed: 28074401
Neuroendocrinology. 2020;110(6):525-534
pubmed: 31484187
J Neurol Surg B Skull Base. 2018 Apr;79(2):117-122
pubmed: 29868315
World Neurosurg. 2018 Feb;110:e1072-e1077
pubmed: 29229338
Int J Clin Pharmacol Biopharm. 1976 Apr;13(3):199-209
pubmed: 950263
Nat Rev Endocrinol. 2016 Mar;12(3):168-76
pubmed: 26794439
J Intensive Care Med. 2005 May-Jun;20(3):127-40
pubmed: 15888900
Hormones (Athens). 2014 Jul-Sep;13(3):420-3
pubmed: 25079469
Endocr Pract. 2019 Sep;25(9):943-950
pubmed: 31170367
Childs Nerv Syst. 1998 Jun;14(6):276-9
pubmed: 9694340
Clin Otolaryngol. 2011 Jun;36(3):212-20
pubmed: 21752205
N Engl J Med. 1987 Apr 23;316(17):1070-4
pubmed: 3561459
Baillieres Clin Endocrinol Metab. 1989 Aug;3(2):473-97
pubmed: 2698145
Acta Endocrinol (Copenh). 1981 May;97(1):23-5
pubmed: 7223315
Endocr Pract. 2015 Jul;21(7):832-8
pubmed: 26172128
J Clin Endocrinol Metab. 2003 Oct;88(10):4709-19
pubmed: 14557445
Pituitary. 2006;9(1):59-64
pubmed: 16703410
Acta Neurochir (Wien). 2006 Mar;148(3):287-91; discussion 291
pubmed: 16362179
Acta Paediatr Scand. 1973 Mar;62(2):133-40
pubmed: 4691456
J Pediatr Endocrinol Metab. 2006 Jul;19(7):919-25
pubmed: 16995572
J Clin Endocrinol Metab. 2007 Jul;92(7):2640-3
pubmed: 17426098
Endokrinologie. 1975 Nov;66(2):184-95
pubmed: 1236681
Clin Endocrinol (Oxf). 1993 Feb;38(2):177-82
pubmed: 8435898
N Engl J Med. 2000 May 18;342(20):1493-9
pubmed: 10816188
J Neurosurg. 2005 Sep;103(3):448-54
pubmed: 16235676
Clin Endocrinol (Oxf). 2011 Jun;74(6):750-5
pubmed: 21521265
Arch Dis Child. 1986 Mar;61(3):247-50
pubmed: 3963868
J Clin Endocrinol Metab. 2015 Jun;100(6):2275-82
pubmed: 25923040
Pituitary. 2006;9(2):93-9
pubmed: 16832585
Endocrine. 2011 Aug;40(1):67-74
pubmed: 21626284
Br Med J. 1974 Jul 13;3(5923):86-9
pubmed: 4851464
J Clin Endocrinol Metab. 2011 Apr;96(4):1046-52
pubmed: 21289257
J Clin Pharmacol. 1976 Oct;16(10 Pt 1):518-24
pubmed: 789414
N Engl J Med. 2018 Aug 02;379(5):428-439
pubmed: 30067922
Clin Endocrinol (Oxf). 1999 Apr;50(4):431-9
pubmed: 10468901
J Neurosurg. 2018 Jun 1;:1-8
pubmed: 29999459
J Neurosurg. 2019 Mar 22;132(4):1043-1053
pubmed: 30901746
Endocr Pract. 2017 Mar;23(3):309-317
pubmed: 27967227
Nat Clin Pract Endocrinol Metab. 2007 Jun;3(6):489-94
pubmed: 17515893
J Clin Endocrinol Metab. 2016 Nov;101(11):3888-3921
pubmed: 27736313
Int J Clin Pharmacol Biopharm. 1976 Dec;14(4):259-65
pubmed: 1002361
Pituitary. 2013 Dec;16(4):445-51
pubmed: 23242859
Clin Chem. 2006 Jan;52(1):112-9
pubmed: 16269513
Cleve Clin J Med. 2006 Jan;73(1):65-71
pubmed: 16444918
Am J Physiol. 1986 Aug;251(2 Pt 2):R214-7
pubmed: 3740301
Endocr J. 2013;60(9):1085-94
pubmed: 23811987
BMJ. 2006 Mar 25;332(7543):702-5
pubmed: 16565125
Neurosurg Clin N Am. 2019 Oct;30(4):515-524
pubmed: 31471059
World Neurosurg. 2017 Nov;107:429-436
pubmed: 28797976

Auteurs

Mussa H Almalki (MH)

Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
Faculty of Medicine, King Saud Bin Abdul Aziz University of Health Sciences, Riyadh, Saudi Arabia.

Maswood M Ahmad (MM)

Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia.

Imad Brema (I)

Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia.

Mohammed Almehthel (M)

Obesity, Endocrine and Metabolism Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
Division of Endocrinology, University of British Columbia, Vancouver, Canada.

Khaled M AlDahmani (KM)

Division of Endocrinology, Tawam Hospital, Al Ain, United Arab Emirates.
Department of Medicine, United Arab Emirates University, Al Ain, United Arab Emirates.

Moeber Mahzari (M)

Faculty of Medicine, King Saud Bin Abdul Aziz University of Health Sciences, Riyadh, Saudi Arabia.
Department of Medicine, Ministry of National Guard Health Affair, Riyadh, Saudi Arabia.

Salem A Beshyah (SA)

Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates.
Department of Endocrinology, Mediclinic Airport Road, Abu Dhabi, United Arab Emirates.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH